AIP
CASC

Ameritas Investment Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Ameritas Investment Partners’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,009
Closed -$11K – 2983
2017
Q4 		$11K Hold
3,009
– – ﹤0.01% 2736
2017
Q3 		$10K Hold
3,009
– – ﹤0.01% 2800
2017
Q2 		$11K Buy
+3,009
New +$11.9K ﹤0.01% 2800

Ameritas Investment Partners's CASC Position: Q1 2018 in Review

Ameritas Investment Partners sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 3,009 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in CASC in Q2 2017 and held it in 3 quarters. The position peaked at $11K in Q4 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • Ameritas Investment Partners reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,009 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $11K.
  • Ameritas Investment Partners first reported a position in Cascadian Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
  • Ameritas Investment Partners's Cascadian Therapeutics, Inc. position peaked at $11K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.